COVID-19 may become a seasonal virus

A hand sanitizer dispenser next to an elevator.
(Image credit: Shutterstock)

COVID-19 may eventually become a seasonal illness like the flu, but only when the population achieves herd immunity, meaning a sufficient number of people are immune to prevent constant spread, a new review article suggests.

But until then, COVID-19 will likely spread year-round, a finding that highlights the importance of following public health measures to control the virus, according to the review, published Tuesday (Sept. 15) in the journal Frontiers in Public Health.

"COVID-19 is here to stay and it will continue to cause outbreaks year-round until herd immunity is achieved," study senior author Hassan Zaraket, an assistant professor of virology at the American University of Beirut in Lebanon, said in a statement. "Therefore, the public will need to learn to live with it and continue practicing the best prevention measures, including wearing of masks, physical distancing, hand hygiene and avoidance of gatherings."

Related: 14 coronavirus myths busted by science

What makes a virus seasonal? 

Many viruses seem to follow seasonal patterns — for example, in temperate regions, cases of the flu regularly peak in winter and dwindle during the summer months. The same is true for certain types of coronaviruses that cause the common cold. 

Scientists don't know for sure why these viruses follow a seasonal pattern, but a number of factors are thought to play a role. For example, studies suggest that many respiratory viruses are more stable and linger in the air longer in environments with cold temperatures and low humidity, the authors said. Human behaviors, such as gathering indoors in wintertime, could also boost transmission.

Early studies on SARS-CoV-2, the virus that causes COVID-19, also suggested that the virus's transmission may increase in colder temperatures and decrease in warmer temperatures.

But with any infectious disease, in order for cases to decline, a factor known as the "basic reproduction number" (R0, pronounced R-nought), or the average number of people who catch the virus from a single infected person, needs to drop below 1.

The R0 for COVID-19 appears to be relatively high, with many scientists estimating a value between 2 and 3, compared with about 1.3 for the flu, the authors said.

COVID-19's high R0 may be due, in part, to the absence of pre-existing immunity to the disease in most of the population. Thus, with a higher R0, the authors predict it will be harder for seasonal factors to push R0 below 1. 

"Therefore, without public health interventions, SARS-CoV-2 will continue to spread in summer as witnessed in many countries around the world," the authors wrote.

In contrast, as more people gain immunity, either through natural infection or vaccine, the R0 "is expected to drop substantially, making the virus more prone to seasonal fluctuations," such as spikes in wintertime and dips in summertime, the authors concluded.

If a COVID-19 vaccine becomes available, it may reduce the spread, but it will likely not totally eliminate the virus, Zaraket and study co-author Hadi Yassine, an associate professor of infectious diseases at Qatar University in Doha, told Live Science in an email. That's because the vaccine will likely not be 100% effective, so some infections will still occur. In addition, the protection offered by the vaccine may wane with time, or the virus may mutate and evade immune protection, the researchers said.

Editor's note: This article was updated on Sept. 15 at 11:45 am ET to include comments from the authors about the possibility of a COVID-19 vaccine becoming available. 

Originally published on Live Science.  

Rachael Rettner
Contributor

Rachael is a Live Science contributor, and was a former channel editor and senior writer for Live Science between 2010 and 2022. She has a master's degree in journalism from New York University's Science, Health and Environmental Reporting Program. She also holds a B.S. in molecular biology and an M.S. in biology from the University of California, San Diego. Her work has appeared in Scienceline, The Washington Post and Scientific American.